![Tony Kingsley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tony Kingsley
Presidente presso
Annovation BioPharma, Inc.
Patrimonio netto: 435 842 $ in data 31/05/2026
Profilo
Stuart Anthony Kingsley is President & Director at Annovation BioPharma, Inc. He is Independent Non-Executive Director at Indivior Pharmaceuticals, Inc. starting 2026 and at Indivior Ltd. starting 2025.
Former roles include President, Chief Executive Officer & Director at TARIS BioMedical LLC in 2019; President, Chief Executive Officer & Director at Scholar Rock, Inc. and Scholar Rock Holding Corp.
from 2020 to 2021; Chief Executive Officer & Director at Stablix, Inc. from 2022 to 2025; Director at Third Wave Technologies, Inc. in 2008; Independent Director at Proteon Therapeutics, Inc. from 2015 to 2019; Senior VP & GM-Gynecological Surgical Products at Hologic, Inc. in 2009; Head-Global Commercial Operations at Biogen, Inc. from 2011 to 2016; President-Diagnostic Products Division & Senior VP at Cytyc Corp.
in 2007; President & Chief Operating Officer at The Medicines Co. from 2016 to 2017; Partner at McKinsey & Co., Inc. until 2006.
Education includes undergraduate degree from Dartmouth College and MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,01% | 13/05/2026 | 12.100 ( 0,01% ) | 435 842 $ | 31/05/2026 |
Posizioni attive di Tony Kingsley
| Società | Posizione | Inizio |
|---|---|---|
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Presidente | - |
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Direttore/Membro del Consiglio | 01/07/2025 |
Precedenti posizioni note di Tony Kingsley
| Società | Posizione | Fine |
|---|---|---|
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Amministratore Delegato | 01/09/2025 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Amministratore Delegato | 03/08/2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Amministratore Delegato | 29/07/2021 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Amministratore Delegato | 31/12/2019 |
| PROTARA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/04/2019 |
Formazione di Tony Kingsley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Develops DNA and RNA detection technology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
